AI Daily Brief

The most important AI developments, once a day. Published at 08:00 UTC.

Subscribe to AI Daily Brief

Get the top 5 stories delivered to your inbox every morning.

June 14, 2026

OpenAI announces GPT-5 with multimodal reasoning

OpenAI unveiled GPT-5, featuring native multimodal reasoning across text, images, audio, and video. The model supports a 2M token context window and shows significant improvements in mathematical reasoning and code generation. Enterprise API pricing starts at $0.03 per 1K tokens.

Key takeaway: This is OpenAI's most capable model to date and could shift the competitive landscape significantly.

Anthropic raises $5B at $60B valuation

Anthropic closed a $5B funding round led by Lightspeed, valuing the company at $60B. Funds will expand compute infrastructure and accelerate Claude development. A European headquarters in London was also announced.

Key takeaway: The valuation reflects strong enterprise demand for Claude and positions Anthropic as a serious competitor to OpenAI.

EU AI Act begins enforcement for foundation models

The EU AI Act entered its first enforcement phase. Foundation model providers with >10^25 FLOPs must comply with transparency obligations, including detailed technical documentation and training data summaries.

Key takeaway: This is the first major regulatory framework for AI at scale. Companies operating in Europe need to assess compliance immediately.

June 13, 2026

Meta open-sources Llama 4 with 400B parameters

Meta released Llama 4, a 400B parameter model with 256K context window. It outperforms GPT-4 on several benchmarks and is available for free commercial use under a new responsible use license.

Key takeaway: Open-source models are catching up to closed frontier models, which could democratize access to high-capability AI.

Google DeepMind AlphaFold 3 achieves 50% better accuracy

AlphaFold 3 improves protein-molecule interaction prediction by 50%, covering DNA, RNA, and small molecules. Available through AlphaFold Server for non-commercial research.

Key takeaway: Drug discovery timelines could be accelerated by years. This is a major breakthrough for structural biology.